Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2017Pediatric Blood & CancerOpen Access

Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas

View Full Paper
Ask AI
Bookmark
Share

Authors

EYE. Ann YehJGJay GreenbergOAOussama Abla

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yeh et al. (2017) studied this question.

synapsesocial.com/papers/6a7cb3fb54aa60bef58ce3ddhttps://doi.org/10.1002/pbc.26784
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cerebellar degeneration caused by high‐dose cytosine arabinoside: A clinicopathological study1983 · 149 citations
  2. 2Permanent consequences in Langerhans cell histiocytosis patients: A pilot study from the Histiocyte Society—Late Effects Study Group2004 · 237 citations